aripiprazole has been researched along with Cannabis Abuse in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foreman, K; Loh, R; Thurstone, C; Thurstone, CA; Wolf, C | 1 |
| Abdullayeva, N; Coffey, BJ; Poulsen, R | 1 |
| Calabrò, G; Caloro, M; Cuomo, I; De Filippis, S; Girardi, P; Kotzalidis, GD; Ranieri, V; Telesforo, CL; Zingaretti, P | 1 |
| Faludi, G; Fejes, L; Inczédy-Farkas, G; Kassai-Farkas, A; Lazáry, J; Makkos, Z | 1 |
| Cottencin, O; Geoffroy, PA; Guardia, D; Rolland, B; Warembourg, F | 1 |
| Akhtar, U; Ambrosini, PJ; Lobach, L; Oluwabusi, OO; Youngman, B | 1 |
| Coffey, B; Jummani, R; Vito, J | 1 |
| Desseilles, M; Mathot, F | 1 |
8 other study(ies) available for aripiprazole and Cannabis Abuse
| Article | Year |
|---|---|
Program Evaluation to Aid Choice of Aripiprazole or Risperidone for Hospitalized Adolescents with Cannabis Use Disorder and Psychosis.
Topics: Adolescent; Adolescent, Hospitalized; Antipsychotic Agents; Aripiprazole; Humans; Marijuana Abuse; Program Evaluation; Psychotic Disorders; Retrospective Studies; Risperidone; Substance-Related Disorders | 2023 |
Acute Dystonic Reaction to Aripiprazole in an Adolescent Boy.
Topics: Adolescent; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Benztropine; Bipolar Disorder; Dystonia; Humans; Lithium; Male; Marijuana Abuse; Quetiapine Fumarate; Risk-Taking | 2020 |
Hiccup with aripiprazole plus benzodiazepines resolving with pregabalin and/or benzodiazepine switch/discontinuation: four case reports.
Topics: Adolescent; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Calcium Channel Blockers; Hiccup; Humans; Male; Marijuana Abuse; Pregabalin; Psychoses, Substance-Induced; Psychotic Disorders; Substance-Related Disorders; Young Adult | 2015 |
[Clinical characteristics of cannabis-induced schizophrenia spectrum disorder].
Topics: Adolescent; Adult; Aggression; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Dibenzothiazepines; Hallucinations; Haloperidol; Humans; Hungary; Male; Marijuana Abuse; Olanzapine; Paranoid Disorders; Piperazines; Psychomotor Performance; Quetiapine Fumarate; Quinolones; Retrospective Studies; Risperidone; Schizophrenia; Schizophrenic Psychology | 2011 |
Use of aripiprazole in treatment of cannabis dependence in a patient presenting with Borderline Personality Disorder.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Diagnosis, Dual (Psychiatry); Female; Humans; Marijuana Abuse; Piperazines; Quinolones | 2012 |
Synthetic cannabinoid-induced psychosis: two adolescent cases.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Cannabinoids; Delusions; Designer Drugs; Humans; Male; Marijuana Abuse; Olanzapine; Piperazines; Psychoses, Substance-Induced; Quinolones | 2012 |
Advanced pediatric psychopharmacology.
Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Cannabinoids; Combined Modality Therapy; Comorbidity; Drug Therapy, Combination; Humans; Male; Marijuana Abuse; Mental Status Schedule; Neuroleptic Malignant Syndrome; Patient Readmission; Piperazines; Prognosis; Psychoses, Substance-Induced; Quinolones; Recurrence; Social Environment; Thiazoles; Treatment Refusal | 2006 |
Aripiprazole diminishes cannabis use in schizophrenia.
Topics: Antipsychotic Agents; Aripiprazole; Humans; Marijuana Abuse; Piperazines; Quinolones; Schizophrenia | 2008 |